4/10
11:20 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
4/10
11:20 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
4/10
10:58 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
4/10
10:58 am
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/26
08:09 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
Medium
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $97.00 price target on the stock.
2/26
06:51 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
2/26
06:51 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
2/16
03:40 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
2/16
03:40 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $114.00 price target on the stock.
2/16
02:34 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/16
02:34 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/16
12:10 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/16
12:10 pm
bpmc
Rating for BPMC
Low
Report
Rating for BPMC
2/13
09:10 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
2/13
09:10 am
bpmc
Rating for BPMC
Medium
Report
Rating for BPMC
2/5
05:10 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $97.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $97.00 price target on the stock.
2/5
05:10 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $97.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $97.00 price target on the stock.